Giant Biogene Holding Balance Sheet Health
Financial Health criteria checks 6/6
Giant Biogene Holding has a total shareholder equity of CN¥4.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥5.0B and CN¥602.0M respectively. Giant Biogene Holding's EBIT is CN¥1.6B making its interest coverage ratio -34. It has cash and short-term investments of CN¥3.8B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | -34x |
Cash | CN¥3.79b |
Equity | CN¥4.37b |
Total liabilities | CN¥602.03m |
Total assets | CN¥4.97b |
Recent financial health updates
No updates
Recent updates
Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?
Apr 17Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings
Mar 28Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 27Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?
Dec 24A Look At The Intrinsic Value Of Giant Biogene Holding Co., Ltd. (HKG:2367)
Oct 30Giant Biogene Holding Co., Ltd.'s (HKG:2367) Share Price Matching Investor Opinion
Mar 28Financial Position Analysis
Short Term Liabilities: 2367's short term assets (CN¥4.1B) exceed its short term liabilities (CN¥530.6M).
Long Term Liabilities: 2367's short term assets (CN¥4.1B) exceed its long term liabilities (CN¥71.4M).
Debt to Equity History and Analysis
Debt Level: 2367 is debt free.
Reducing Debt: 2367 has not had any debt for past 5 years.
Debt Coverage: 2367 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 2367 has no debt, therefore coverage of interest payments is not a concern.